Teaching Doctors in Training to Reason With Artificial Intelligence (TEACH-AI)
Teaching Internal Medicine and Family Medicine Residents to Reason With Generative AI: A Multi-Site Randomized Controlled Trial (TEACH-AI)
The purpose of the TEACH-AI study is to assess whether a brief, structured workshop on artificial intelligence can improve the performance of medicine doctors in training (i.e. residents) in their diagnostic and management reasoning.
In this multi-site randomized controlled trial, internal medicine and family medicine residents are assigned either to receive an in-person workshop on safe, effective LLM use before a standardized AI-assisted assessment, or to complete the same assessment before receiving the workshop. Residents will review clinical cases that are fully synthetic, no protected health information is used, using a password protected LLM interface.
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
Large language models (LLMs) have rapidly entered routine use in medical education and clinical practice. Prior randomized trials have shown that, although LLMs can outperform individual clinicians on some reasoning benchmarks, providing physicians with access to an LLM does not necessarily improve their diagnostic or management performance, and LLMs alone may perform better than physician-plus-LLM teams. These findings suggest that human-AI collaboration is fraught, non-trivial and may require explicit training.
TEACH-AI is a pragmatic, multi-site, two-arm randomized controlled trial embedded within protected residency didactic time. The primary objective is to determine whether a single in-person workshop on the basics of LLMs and best practices of prompting/verification strategies improves residents' performance on an AI-assisted assessment, compared with residents who complete the simulation before receiving the workshop. All participants will ultimately receive the same workshop and the same assessment (either workshop-first vs assessment-first).
The simulation consists of multiple fully synthetic vignettes delivered via a password protected LLM interface. Residents interact freely with the LLM using natural-language prompts and then submit structured final responses regarding aspects such as leading diagnosis, differential, management plan, and/or justification. The platform will record prompts, model outputs, final answers, and timing. Vignette scoring combines correctness of the final diagnosis or management plan. Scoring is conducted by blinded faculty using standardized rubrics and then any discrepancies will be resolved through multiple rounds of discussions.
The trial will enroll up to 200 residents across four ACGME-accredited programs (internal medicine at Beth Israel Deaconess Medical Center, Stanford University, and Cambridge Health Alliance; family medicine at AdventHealth Orlando).
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Jacob M Koshy, MD, MPH
- Número de telefone: 617-754-4677
- E-mail: jkoshy@bidmc.harvard.edu
Locais de estudo
-
-
California
-
Palo Alto, California, Estados Unidos, 94305
- Stanford University
-
Contato:
- Kevin Keet, MD
- Número de telefone: 650-498-4559
- E-mail: kkeet@stanford.edu
-
Investigador principal:
- Kevin R Keet, MD
-
-
Florida
-
Orlando, Florida, Estados Unidos, 32804
- AdventHealth
-
Contato:
- Raj Mehta, MD
- Número de telefone: 407-845-8383
- E-mail: raj.mehta.md@adventhealth.com
-
Investigador principal:
- Raj Mehta, MD
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02215
- Beth Israel Deaconess Medical Center
-
Contato:
- Jacob M Koshy, MD, MPH
- Número de telefone: 617-754-4677
- E-mail: jkoshy@bidmc.harvard.edu
-
Investigador principal:
- Jacob M Koshy, MD, MPH
-
Cambridge, Massachusetts, Estados Unidos, 02139
- Cambridge Health Alliance
-
Contato:
- Priyank Jain, MD
- Número de telefone: 617-665-1000
-
Investigador principal:
- Priyank Jain, MD
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Participants must be licensed physicians and have started at least post-graduate year 1 (PGY1) of medical training.
- Training in Internal medicine or family medicine or emergency medicine.
- Able to provide informed consent and complete assessments in English.
Exclusion Criteria:
- Not currently practicing clinically.
- Resident directly involved in the design of the study, development of the workshop, or creation/piloting of the assessment vignettes.
- Resident who declines or withdraws consent.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Diagnóstico
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Sem intervenção: Assessment-First
Participants assigned to this group will be tasked with completing the assessment using a password protected LLM interface first in advance of the workshop.
The workshop will be delivered during a scheduled mandatory didactic time slot.
|
|
|
Experimental: Workshop-first
Participants assigned to this group will be tasked with completing the assessment using a password protected LLM interface after they participate in a scheduled mandatory didactic time slot.
|
Participants will attend a workshop during their didactic time that will review various aspects of large language models including fundamentals and best practices of interacting and interpreting their outputs.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Total Score on Expert-Development Rubrics
Prazo: Within 24 hours of assessment completion.
|
The primary outcome will be the number of correct responses for all cases using select questions from expert-developed scoring rubrics.
The rubrics were developed using a Delphi consensus process by expert physicians as established by Goh et al (Nature Medicine, 2025; DOI: 10.1038/s41591-024-03456-y). The primary outcome will be analyzed at the case level, comparing performance between the randomized study groups, with a higher number of correct responses indicating a better outcome.
|
Within 24 hours of assessment completion.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Time Spent on Management
Prazo: Within 24 hours of assessment completion.
|
Comparison of time spent per case between the two study groups.
|
Within 24 hours of assessment completion.
|
|
Prompt Count
Prazo: Within 24 hours of assessment completion.
|
Comparison of the number of resident-initiated prompts to the LLM per case between the two study groups.
|
Within 24 hours of assessment completion.
|
|
Management Reasoning Using Expert-Derived Rubrics
Prazo: Within 24 hours of assessment completion.
|
Comparison of management reasoning accuracy based on the number of correct responses per case between the two groups on expert-developed scoring rubrics.
The rubrics were developed using a Delphi consensus process by expert physicians as established by Goh et al (Nature Medicine, 2025; DOI: 10.1038/s41591-024-03456-y). The primary outcome will be analyzed at the case level, comparing performance between the randomized study groups with more correct responses indicating a better outcome.
|
Within 24 hours of assessment completion.
|
|
Diagnostic Reasoning
Prazo: Within 24 hours of assessment completion.
|
Comparison of diagnostic reasoning accuracy based on the number of correct responses per case between the two groups.
|
Within 24 hours of assessment completion.
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- 2026P000369
- 63901784-350738 (Número de outro subsídio/financiamento: Macy Foundation)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .